Profile
Full Name
Kyverna Therapeutics, Inc.Ticker Symbol
KYTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 9, 2024Indexes
Not includedWebsite
http://kyvernatx.comEmployees
112Key Details
Price
$2.06(+10.16%)
Market cap
$89.02M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.33(-125.20% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Kyverna Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 3, 25 HC Wainwright & Co.
NeutralApr 1, 25 Morgan Stanley
OverweightNov 20, 24 HC Wainwright & Co.
NeutralNov 15, 24 Wells Fargo
OverweightOct 10, 24 UBS
BuySep 19, 24 HC Wainwright & Co.
NeutralAug 15, 24 HC Wainwright & Co.
NeutralJul 31, 24 JP Morgan
OverweightJul 16, 24 HC Wainwright & Co.
NeutralJul 3, 24 HC Wainwright & Co.
NeutralInstitutional Ownership
- What is the ticker symbol for Kyverna Therapeutics?
- Does Kyverna Therapeutics pay dividends?
- What sector is Kyverna Therapeutics in?
- What industry is Kyverna Therapeutics in?
- What country is Kyverna Therapeutics based in?
- When did Kyverna Therapeutics go public?
- Is Kyverna Therapeutics in the S&P 500?
- Is Kyverna Therapeutics in the NASDAQ 100?
- Is Kyverna Therapeutics in the Dow Jones?
- When was Kyverna Therapeutics's last earnings report?
- When does Kyverna Therapeutics report earnings?
- Should I buy Kyverna Therapeutics stock now?
What is the ticker symbol for Kyverna Therapeutics?
The ticker symbol for Kyverna Therapeutics is NASDAQ:KYTX
Does Kyverna Therapeutics pay dividends?
No, Kyverna Therapeutics does not pay dividends
What sector is Kyverna Therapeutics in?
Kyverna Therapeutics is in the Healthcare sector
What industry is Kyverna Therapeutics in?
Kyverna Therapeutics is in the Biotechnology industry
What country is Kyverna Therapeutics based in?
Kyverna Therapeutics is headquartered in United States
When did Kyverna Therapeutics go public?
Kyverna Therapeutics's initial public offering (IPO) was on February 9, 2024
Is Kyverna Therapeutics in the S&P 500?
No, Kyverna Therapeutics is not included in the S&P 500 index
Is Kyverna Therapeutics in the NASDAQ 100?
No, Kyverna Therapeutics is not included in the NASDAQ 100 index
Is Kyverna Therapeutics in the Dow Jones?
No, Kyverna Therapeutics is not included in the Dow Jones index
When was Kyverna Therapeutics's last earnings report?
Kyverna Therapeutics's most recent earnings report was on Mar 27, 2025
When does Kyverna Therapeutics report earnings?
The next expected earnings date for Kyverna Therapeutics is May 30, 2025
Should I buy Kyverna Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions